Health ❯Clinical Trials

Phase 1 Trials

Weight Loss Medications Patient Recruitment Drug Mechanism

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

The pharmaceutical giant partners with Danish firm Gubra to develop an experimental amylin-based weight-loss treatment currently in Phase 1 trials.

Xenon Gas Shows Promise as Potential Alzheimer's Treatment in Mouse Study

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial